Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Club doctors and physiotherapists

C Hay

    British Journal of Sports Medicine
    |May 29, 2001
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First-line immune tolerance induction for children with severe haemophilia A: A protocol from the UK Haemophilia Centre Doctors' Organisation Inhibitor and Paediatric Working Parties.

    Haemophilia : the official journal of the World Federation of Hemophilia·2017
    Same author

    Hindfoot fusion in haemophilic arthropathy: 6-year mean follow-up of 41 procedures performed in 28 adult patients.

    Haemophilia : the official journal of the World Federation of Hemophilia·2017
    Same author

    European retrospective study of real-life haemophilia treatment.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq<sup>®</sup> ) in adults with severe haemophilia A: efficacy and safety.

    Haemophilia : the official journal of the World Federation of Hemophilia·2015
    Same author

    Can (1)H MR Spectroscopy be Used to Assess the Success of Uterine Artery Embolisation?

    Cardiovascular and interventional radiology·2015
    Same author

    Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial.

    Journal of thrombosis and haemostasis : JTH·2015